These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2557108)

  • 1. Unitary models of schizophrenia.
    Br J Psychiatry; 1989 Mar; 154():414-8. PubMed ID: 2557108
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.
    Collinge J; Curtis D
    Br J Psychiatry; 1991 Dec; 159():857-9. PubMed ID: 1665098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there neurochemical indicators of risk for schizophrenia?
    Csernansky JG; Newcomer JW
    Schizophr Bull; 1994; 20(1):75-88. PubMed ID: 7910978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matching clinical and biological specificity: implications for biological psychiatry.
    Pivik RT
    J Psychiatry Neurosci; 1992 Oct; 17(4):132. PubMed ID: 1450185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between genetic polymorphism of dopamine receptor and schizophrenia and its forensic significance].
    Yao J; Wang BJ
    Fa Yi Xue Za Zhi; 2014 Jun; 30(3):202-6. PubMed ID: 25272877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Receptor polymorphism and response to treatment in schizophrenia].
    Szekeres G; Janka Z
    Orv Hetil; 2002 Sep; 143(35):2027-33. PubMed ID: 12387196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems.
    Dollfus S; Campion D; Vasse T; Preterre P; Laurent C; d'Amato T; Thibaut F; Mallet J; Petit M
    Biol Psychiatry; 1996 Sep; 40(5):419-21. PubMed ID: 8874845
    [No Abstract]   [Full Text] [Related]  

  • 8. Amino acid patterns in schizophrenia: some new findings.
    Macciardi F; Lucca A; Catalano M; Marino C; Zanardi R; Smeraldi E
    Psychiatry Res; 1990 Apr; 32(1):63-70. PubMed ID: 2161549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

  • 10. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia.
    Rybakowski JK; Borkowska A; Czerski PM; Kapelski P; Dmitrzak-Weglarz M; Hauser J
    J Neural Transm (Vienna); 2005 Nov; 112(11):1575-82. PubMed ID: 15785860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.
    Harrison PJ; McLaughlin D; Kerwin RW
    Lancet; 1991 Feb; 337(8739):450-2. PubMed ID: 1671470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of cognitive deficit in schizophrenia].
    Golimbet VE
    Mol Biol (Mosk); 2008; 42(5):830-9. PubMed ID: 18988532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of PCP, NMDA and opiate receptors.
    Wilkins J
    NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034
    [No Abstract]   [Full Text] [Related]  

  • 14. New perspectives on the clinical neurobiology of treatment response in schizophrenia.
    Honer WG
    Can J Psychiatry; 1994 Feb; 39(1):34-42. PubMed ID: 7910778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor genes: new tools for molecular psychiatry.
    Niznik HB; Van Tol HH
    J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A role of interactions between N-methyl-D-aspartate and dopamine receptors in facial emotion recognition impairment in schizophrenia].
    Alfimova MV; Golimbet VE; Korovaitseva GI; Lezheiko TV; Tikhonov DV; Ganisheva TK; Berezin NB; Snegireva AA; Shemiakina TK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):47-52. PubMed ID: 28745671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].
    Kornhuber J; Weller M
    Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?
    Carlsson M; Carlsson A
    Schizophr Bull; 1990; 16(3):425-32. PubMed ID: 1981107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic approaches to cognitive enhancement in schizophrenia.
    Burdick KE; Gopin CB; Malhotra AK
    Harv Rev Psychiatry; 2011; 19(3):102-8. PubMed ID: 21631157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
    Morell RT
    J Med Genet; 1993 Aug; 30(8):708-9. PubMed ID: 8411063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.